Funding to Scale Virtual and In-Home Care, Enhance Clinical Innovation, and Support Vulnerable Pediatric Populations Nationwide; Round Includes Continued Support…
FDA has completed its review of the rationale document titled, “Aminoglycoside Breakpoints for Enterobacterales and Pseudomonas aeruginosa” submitted by the…